110535 ⎘
ssDNA viruses; Details; Parvoviridae; Dependovirus, e.g. adenoassociated viruses Viruses as such, e.g. new isolates, mutants or their genomic sequences
Delivery of MECP2 polynucleotide using recombinant AAV9
#302FROG/TOAD conditionally silenced vectors for hypoxia gene therapy
#303Mutated structural protein of a parvovirus
#304AAV capsid proteins for nucleic acid transfer
#305Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same
#306Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#307PRODUCTS AND METHODS FOR DELIVERY OF POLYNUCLEOTIDES BY ADENO-ASSOCIATED VIRUS FOR LYSOSOMAL STORAGE DISORDERS
#308Bovine adeno-associated viral (BAAV) vector and uses thereof
#309EXPRESSION OF VIRUS ENTRY INHIBITORS AND RECOMBINANT AAV THEREFOR
#310Adeno-associated virus virions with variant capsid and methods of use thereof
#311Materials and methods for the treatment of pathological neovascularization in the eye
#312Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#313ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#314PARVOVIRAL CAPSID WITH INCORPORATED GLY-ALA REPEAT REGION
#315Method for detecting adeno-associated virus
#316Directed evolution and in vivo panning of virus vectors
#317Adeno-Associated Virus Materials and Methods
#318Duplexed parvovirus vectors
#319ADENO-ASSOCIATED VIRUS SEROTYPE I NUCLEIC ACID SEQUENCES, VECTORS AND HOST CELLS CONTAINING SAME
#320Porcine adeno-associated viruses
#321Baculoviral vectors comprising repeated coding sequences with differential codon biases
#322MUTATED STRUCTURAL PROTEIN OF A PARVOVIRUS
#323Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
#324Mutant adeno-associated virus virions and methods of use thereof
#325Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#326Expression of virus entry inhibitors and recombinant AAV therefor
#327Transcytosis of Adeno-Associated Viruses
#328Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same
#329Adeno-associated virus serotype I nucleic acid sequences, vectors and host cell containing same
#330AAV virions with decreased immunoreactivity and uses therefor
#331Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
#332Self-complementary parvoviral vectors, and methods for making and using the same
#333Duplexed parvovirus vectors
#334Avian adenoassociated virus and uses thereof
#335Bovine adeno-associated viral (BAAV) vector and uses thereof
#336Expression of virus entry inhibitors and recombinant AAV thereof
#337Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#338Adeno-associated virus materials and methods
#339Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
#340AAV virions with decreased immunoreactivity and uses therefor
#341Adeno-associated virus materials and methods
#342Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors
#343Adeno-associated virus variant